Fabio Lau

Fabio Lau

Auto-generated profile, based on publicly available information

Fabio Lau

Universidade Estadual de Campinas (UNICAMP), Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço, Campinas, SP, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2024 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
FGFabio Portella Gazmenga
Fabio Portella Gazmenga
MTMariana Dalbo Contrera Toro
Mariana Dalbo Contrera Toro
FLFabio Lau
Fabio Lau
ACArthur Jose Roque Cruz
Arthur Jose Roque Cruz
ECElaine Costa
Elaine Costa
ESEulalia Sakano
Eulalia Sakano
To perform the translation, cultural adaptation, and validation of the NOSE-Perf Scale to Brazilian Portuguese. This study was divided into two stages. In the first stage, the questionnaire was submitted for translation and cultural adaptation, following the guidelines recommended by the ISPOR Task Force (International Society for Pharmacoeconomics and Outcomes Research). Then, the Brazilian Portuguese version of the NOSE-Perf scale was applied to a group with septal perforation and a control group. The group with perforation answered the questionnaire again after one month. Internal consistency, test-retest reliability, and discriminant validity were assessed. The Brazilian Portuguese version of the NOSE-Perf scale was applied to 32 participants, 16 from the group with septal perforations and 16 controls. The instrument obtained high internal consistency, with Cronbach's alpha scores of 0.986. High reliability was also obtained, with Spearman's correlation coefficient of 0.996 (p < 0.001) and the intraclass correlation coefficient of 0.965 with a 95% Confidence Interval (95% CI) of 0.886‒0.988. The NSP group obtained a mean total score of 13.8 ± 12.6 and the control group a score of 2.3 ± 1.8, with a statistical difference between the groups (p < 0.001), demonstrating good discriminant validity. The Brazilian Portuguese version of the NOSE-Perf scale is a reliable and valid instrument for measuring symptoms in patients with nasal septum perforations. Level 2-Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence.

23 September 2023 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
FLFabio Lau
Fabio Lau
MLMatheus Lisatchok
Matheus Lisatchok
JTJonas Belchior Tamanini
Jonas Belchior Tamanini
FGFabio Portela Gazmenga
Fabio Portela Gazmenga
DTDaniel Naves Araújo Texeira
Daniel Naves Araújo Texeira
CCCarlos Takahiro Chone
Carlos Takahiro Chone
According to an extensive database, the Objective is to compare surgical versus non-surgical treatment through Propensity Score (PS) for patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC). We retrospectively evaluated epidemiological data from 8075 patients with OPSCC diagnosed between 2004 and 2014 and used PS matching to analyze possible prognostic factors for its outcomes with regression analyses. Cox multiple regression analysis to study survival after PS matching shows that type of treatment was associated with death with a hazard ratio of 1.753 (p0.05). In the surgical treatment group, overall survival was 79.9% at one year, 36.4% at five years, and 20.5% at ten years. Disease-free survival was 90.1%, 64.8%, and 56.0% at 1, 5, and 10-years, respectively. In the non-surgical treatment group, overall survival was 60.6% at one year, 21.8% at five years, and 12.7% at ten years. Disease-free survival was 90.8%, 67.2%, and 57.8% at 1, 5, and 10-years, respectively. Patients in the surgical treatment group had better outcomes related to survival. Recurrence is associated with the survival of OPSCC cancer. Recurrence-free survival is similar to both treatments. 2C.

26 March 2026 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
GMGustavo Mercuri
Gustavo Mercuri
IGIsabella Grieger
Isabella Grieger
DADaniel Naves de Araújo
Daniel Naves de Araújo
FLFabio Lau
Fabio Lau
CCCarlos Takahiro Chone
Carlos Takahiro Chone
This study aimed to analyze prognostic factors associated with survival and recurrence in patients with Oral Cavity Squamous Cell Carcinoma (OCSCC) treated in São Paulo, Brazil. The investigation focused on evaluating the influence of clinical stage, treatment modality, age, and sex on overall and recurrence-free survival in a large cohort derived from a public cancer registry. Single-center retrospective observational study with a cross-sectional and quantitative design. São Paulo, Brazil. A retrospective analysis was conducted using data from 10,122 patients diagnosed with OCSCC between 2004 and 2014, obtained from the Oncocenter Foundation of São Paulo (FOSP) database. The primary endpoint was Overall Survival (OS), and secondary endpoints included Recurrence-Free Survival (RFS), Disease-Free Survival (DFS), and Local Recurrence-Free Survival (LRFS). Prognostic factors were assessed through univariable and multivariable Cox proportional hazards models. Kaplan-Meier curves were used to estimate survival, and comparisons were made using the log-rank test. The mean follow-up time was 39.37 ± 37.93 months. Age ranged from 11- to 104-years, with a mean age of 60.2 ± 12.6 years at diagnosis, and 78.3% were male. Most patients (61.97%) were diagnosed at an advanced stage (III-IV). Advanced stage and non-surgical treatment were independently associated with worse OS (HR = 4.253, 95% CI 3.883-4.659; 2.546, 95% CI 2.381-2.722, respectively). The 5-year overall survival rate was 50.3%, with a mean survival interval of 6.70 ± 0.06 years after diagnosis. Elderly patients and men had higher recurrence and mortality risks, whereas early-stage disease and surgical treatment were associated with better outcomes. Advanced clinical stage and non-surgical treatment were the strongest independent prognostic factors for decreased survival in OSCC. These findings underscore the importance of early detection and surgical management, as well as the need for public health strategies to reduce diagnostic and treatment delays in Brazil. 2B.

3 May 2025 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
DTDaniel Naves Araujo Teixeira
Daniel Naves Araujo Teixeira
FLFabio Lau
Fabio Lau
VOVanessa Carvalho de Oliveira
Vanessa Carvalho de Oliveira
ECEduardo Vieira Couto
Eduardo Vieira Couto
TMThomas Peter Maahs
Thomas Peter Maahs
CCCarlos Takahiro Chone
Carlos Takahiro Chone
To estimate patients' overall and disease-free survival with squamous cell carcinoma of the oral cavity, oropharynx, and larynx, and assess the influence of primary local staging and histopathological features on these outcomes. Retrospective data analysis of 102 patients with head and neck squamous cell carcinoma who underwent exclusive surgery as the initial treatment modality. p16 analysis was not evaluated. Exclusion criteria included patients with synchronous or metachronous tumors, those undergoing adjuvant or neoadjuvant chemotherapy or radiotherapy, and those with prior surgery at the exact site. Univariate and multivariate Cox Regression analyses were performed to evaluate outcome-related factors. Survival curves were estimated using the Kaplan-Meier method. The majority presented early stage I and II (83.4%), T1/T2 tumors (86.2%), N0 (95.1%), and all M0. The primary sites were mainly the larynx (46.1%) and oral cavity (41.2%). The mean overall survival was 71.76 months, with survival rates at 1-, 2-, 3-, 4-, and 5-years of 95.9%, 88.2%, 85.5%, 80.4%, and 74.7%, respectively. The mean disease-free survival was 68.2 months, with rates at 1-, 2-, 3-, 4-, and 5-years of 87.5%, 85.1%, 82.2%, 76.6%, and 69.3%, respectively. Active smoking was associated with a higher risk of death (HR = 9.4, p < 0.001) and recurrence (HR = 9.7, p < 0.001). Active smoking patients with perineural invasion presented worse overall and disease-free survival. Positive margins were associated with reduced disease-free survival. Exclusive surgery in the early stages (I and II) emerges as a practical approach. Stage, primary site, margins, perineural invasion, lymphovascular invasion, and smoking cessation were the significant prognostic factors that affected patient outcomes. 2C.

17 October 2021 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
AAAmanda Sampaio Almeida
Amanda Sampaio Almeida
FGFlavio Mignone Gripp
Flavio Mignone Gripp
FLFabio Lau
Fabio Lau
ECEduardo Vieira Couto
Eduardo Vieira Couto
CCCarlos Takahiro Chone
Carlos Takahiro Chone
This study aims to describe a new secondary tracheoesophageal puncture technique with voice prosthesis insertion under local anesthesia with a low-cost device and evaluate its outcome. With a transoral flexible transillumination device of aluminum of 2.3 mm with fiberoptic light, the esophagus’s anterior wall is visualized through the tracheostomy. A tracheoesophageal fistula is made with a blade and passed through the fistula. Then a bent trocar is introduced into the lumen using the device as a guidewire. Once in the lumen, a thin guide wire is passed through up to the mouth. The voice prosthesis is positioned with retrograde insertion. Then, the patient is discharged without hospitalization. 15 patients submitted to this technique had a successful surgical outcome. There were no complications as pneumothorax, esophageal perforation, bleeding, or hospitalization. The new device is feasible under local anesthesia.

18 April 2025 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
FGFabio Portella Gazmenga
Fabio Portella Gazmenga
MTMariana Dalbo Contrera Toro
Mariana Dalbo Contrera Toro
FLFabio Lau
Fabio Lau
LSLuciana Schultz
Luciana Schultz
ESEulalia Sakano
Eulalia Sakano